Default company panoramic image


Medical device to relieve pain and extend the time to hip replacement for osteoarthritis of the hip patients. No FDA hurdle. Product launched.

  • Stage Full Product Ready
  • Industry Medical Devices and Equipment
  • Location Portland, OR, USA
  • Currency USD
  • Founded September 2009
  • Employees 6
  • Website

Company Summary

Company develops and markets medical devices for the physical therapy (PT) market. First launched product is HipTrac, a Class I Device needing no further FDA approval and targeted at hip osteoarthritis (OA) patients. Hip OA is common and afflicts ca. 15-24 million people, 1/4 over 60. HipTrac relieves pain and delays surgery and is used by the patient at home as an adjunct to PT.


  • Default avatar
    Duffy DuFresne

    Duffy has over 30 years of experience in biopharma and medical device industries.
    * Baxter Labs, general management responsibilities, US and International.
    * Managing Director of Canadian sub of a Drug Co.
    * President or CEO of five medical device or biotech firms.
    * Raised ~$200 million in equity for those firms. Two IPO's.
    * Negotiated many licensing and M&A transactions.
    * New product dev and market launches experience.
    * Harvard

  • Default avatar
    Tony Rocklin
    Founder, CSO

    Dr. Rocklin founded Medrock.
    * A licensed physical therapist with 15 years of experience in sports medicine and orthopedic rehabilitation.
    * A Partner in Therapeutic Associates, a network of ~75 PT-owned clinics across OR, WA, ID and CA.
    * Pacific University, MS, Physical Therapy (1998) and Clinical Doctorate in Physical Therapy (2008).
    Advanced education and certification in orthopedic manual and manipulative therapy.

  • Default avatar
    Michael Tippie
    VP, Business Development

    Michael has more than 25 years of life science experience.
    * Roles in five early stage life science firms as Director of Sales, VP, Bus. Dev, CFO, President, CEO.
    * Life science venture roles (Norwest Venture Capital, Medical Innovation Partners).
    * Negotiated many licenses and strategic alliances.
    * 2 IPO's. Many financings.
    * MIT/Sloan School of Management, MBA, MS, Chemistry, Univ of WA.


  • Default avatar
    Joel Kaplan, Oregon Law Group Beaverton, OR
    Default avatar
    John Konsin
    Board Member